实体瘤-话题@MedSci

#实体瘤#

26篇内容 | 5859人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2118786, encodeId=5ece2118e862e, content=<a href='/topic/show?id=897f10555688' target=_blank style='color:#2F92EE;'>#德喜曲妥珠单抗#</a>（<a href='/topic/show?id=aaf66e9716' target=_blank style='color:#2F92EE;'>#Enhertu#</a>，<a href='/topic/show?id=2f1862e434' target=_blank style='color:#2F92EE;'>#DS-8201#</a>）II期临床数据在泛HER2表达晚期<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>的持久反应，Enhertu（5.4mg/kg）治疗HER2表达肿瘤的疗效和安全性，包括<a href='/topic/show?id=a9ef83546d6' target=_blank style='color:#2F92EE;'>#胆道癌#</a>、<a href='/topic/show?id=843a85e9421' target=_blank style='color:#2F92EE;'>#膀胱癌#</a>、<a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宫颈癌#</a>、<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>、<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a>、<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>和罕见肿瘤。<a href='/topic/show?id=e0df9e832a7' target=_blank style='color:#2F92EE;'>#阿斯利康#</a>和<a href='/topic/show?id=446ae5737da' target=_blank style='color:#2F92EE;'>#第一三共#</a>会收获很多，<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>大概率会批准Enhertu为HER2阳性<a href='/topic/show?id=fdfe10555ef9' target=_blank style='color:#2F92EE;'>#泛癌肿适应症#</a>！这就牛了，是<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>第一个靶向药物。, objectTitle=德喜曲妥珠单抗（Enhertu）II期临床数据在泛HER2表达晚期实体瘤的持久反应（DESTINY-PanTumor02研究）, objectType=article, longId=762351, objectId=656ce623519a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230111/c366160a3bd44df480b7eb8f2aa7eb36.jpg, objectUrl=/article/show_article.do?id=656ce623519a, replyNumber=1, likeNumber=270, createdTime=2023-03-11, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=656ce623519a, moduleTitle=德喜曲妥珠单抗（Enhertu）II期临床数据在泛HER2表达晚期实体瘤的持久反应（DESTINY-PanTumor02研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=656ce623519a)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2274645, encodeId=2f6e22e464576, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗体偶联药物#</a>, objectTitle=读书报告 | 靶向B7H3的ADC在进展期实体瘤的I/Ib期研究, objectType=article, longId=887852, objectId=06d488e852e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=06d488e852e5, replyNumber=0, likeNumber=7, createdTime=2025-07-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=06d488e852e5, moduleTitle=读书报告 | 靶向B7H3的ADC在进展期实体瘤的I/Ib期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06d488e852e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2273866, encodeId=59a322e3866f3, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=ab5e5e376a4' target=_blank style='color:#2F92EE;'>#放射性药物#</a>, objectTitle=Science Adv：放射性药物疗法联合CAR-T助力实体瘤治疗, objectType=article, longId=887118, objectId=5b5e88e118ac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720150214732_5579292.png, objectUrl=/article/show_article.do?id=5b5e88e118ac, replyNumber=0, likeNumber=19, createdTime=2025-07-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b5e88e118ac, moduleTitle=Science Adv：放射性药物疗法联合CAR-T助力实体瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5e88e118ac)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2273415, encodeId=ced122e34156e, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=ae65128585c9' target=_blank style='color:#2F92EE;'>#醛缩酶#</a> <a href='/topic/show?id=a911128586b2' target=_blank style='color:#2F92EE;'>#F-肌动蛋白波#</a>, objectTitle=癌细胞为何偏爱“糖”？Nat Commun：癌细胞竟把“电厂”搬到细胞膜，糖酵解波成全球抗癌研究新热点, objectType=article, longId=886645, objectId=1cbb8866455f, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20250714/1752501249021_1938376.webp, objectUrl=/article/show_article.do?id=1cbb8866455f, replyNumber=0, likeNumber=5, createdTime=2025-07-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2271568, encodeId=a5dd22e15688b, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=333a6802212' target=_blank style='color:#2F92EE;'>#特瑞普利单抗#</a>, objectTitle=STTT：四川大学郑莉等团队研究调查了onatasertib联合特瑞普利单抗治疗晚期实体瘤患者的安全性、耐受性和有效性, objectType=article, longId=882157, objectId=1a6788215e50, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250219/1739953344506_8538692.jpg, objectUrl=/article/show_article.do?id=1a6788215e50, replyNumber=0, likeNumber=31, createdTime=2025-07-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1a6788215e50, moduleTitle=STTT：四川大学郑莉等团队研究调查了onatasertib联合特瑞普利单抗治疗晚期实体瘤患者的安全性、耐受性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a6788215e50)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2269051, encodeId=e71b226905157, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=4e2640e283' target=_blank style='color:#2F92EE;'>#CAR-T细胞#</a> <a href='/topic/show?id=5789e10245' target=_blank style='color:#2F92EE;'>#Eva1#</a>, objectTitle=J Immunother Cancer：新突破！靶向Eva1的CAR-T细胞在实体瘤治疗中或能发挥巨大潜力, objectType=article, longId=881923, objectId=c4de88192306, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250611/1749631642114_1938376.png, objectUrl=/article/show_article.do?id=c4de88192306, replyNumber=0, likeNumber=12, createdTime=2025-06-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2267237, encodeId=986c226e23725, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=Cell：新型CAR-T细胞分子设计方式可加强对实体瘤的杀伤特异性, objectType=article, longId=874718, objectId=a8ae8e47181f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240508/1715158312120_92910.png, objectUrl=/article/show_article.do?id=a8ae8e47181f, replyNumber=0, likeNumber=32, createdTime=2025-05-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a8ae8e47181f, moduleTitle=Cell：新型CAR-T细胞分子设计方式可加强对实体瘤的杀伤特异性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8ae8e47181f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2267179, encodeId=5d58226e17971, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=83b112e3959a' target=_blank style='color:#2F92EE;'>#肿瘤预后评分#</a>, objectTitle=Royal Marsden医院的肿瘤预后评分（RMH得分）, objectType=article, longId=879649, objectId=77f18e9649e7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250221/1740101200194_8538692.jpg, objectUrl=/article/show_article.do?id=77f18e9649e7, replyNumber=0, likeNumber=12, createdTime=2025-05-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=77f18e9649e7, moduleTitle=Royal Marsden医院的肿瘤预后评分（RMH得分）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77f18e9649e7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2264395, encodeId=5aca226439583, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=0e9b126e767b' target=_blank style='color:#2F92EE;'>#KRASG12C突变#</a> <a href='/topic/show?id=247c126e7765' target=_blank style='color:#2F92EE;'>#D3S-001#</a>, objectTitle=Nat. Med | 新一代KRAS抑制剂D3S-001在KRASG12C突变实体瘤中的I期临床试验：安全性和抗肿瘤活性的初步评估, objectType=article, longId=875442, objectId=fc898e5442e8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250414/1744614391971_1614372.png, objectUrl=/article/show_article.do?id=fc898e5442e8, replyNumber=0, likeNumber=26, createdTime=2025-05-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fc898e5442e8, moduleTitle=Nat. Med | 新一代KRAS抑制剂D3S-001在KRASG12C突变实体瘤中的I期临床试验：安全性和抗肿瘤活性的初步评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc898e5442e8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2264227, encodeId=c6d8226422eb5, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=2620126e42e3' target=_blank style='color:#2F92EE;'>#T细胞治疗#</a>, objectTitle=读书报告 | T细胞治疗引领实体瘤治疗潮流, objectType=article, longId=874404, objectId=68be8e4404f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=68be8e4404f5, replyNumber=0, likeNumber=23, createdTime=2025-05-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=68be8e4404f5, moduleTitle=读书报告 | T细胞治疗引领实体瘤治疗潮流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68be8e4404f5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2261427, encodeId=37df226142ebf, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=a8c0108034bd' target=_blank style='color:#2F92EE;'>#小细胞外囊泡#</a>, objectTitle=减少自相残杀！CAR-T细胞疗法新进展，最新Nature Cancer！, objectType=article, longId=872800, objectId=7f178e280052, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220804/1659580207492_8252897.webp, objectUrl=/article/show_article.do?id=7f178e280052, replyNumber=0, likeNumber=32, createdTime=2025-04-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f178e280052, moduleTitle=减少自相残杀！CAR-T细胞疗法新进展，最新Nature Cancer！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f178e280052)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2259481, encodeId=89c4225948116, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=dc6485068dc' target=_blank style='color:#2F92EE;'>#脑膜转移#</a>, objectTitle=大咖谈 | 实体瘤柔脑膜转移的诊断和治疗, objectType=article, longId=870542, objectId=aced8e05421f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=aced8e05421f, replyNumber=0, likeNumber=33, createdTime=2025-04-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aced8e05421f, moduleTitle=大咖谈 | 实体瘤柔脑膜转移的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aced8e05421f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2258573, encodeId=bfd922585e3c0, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗体偶联药物#</a>, objectTitle=中国原研ADC药物YL201实现晚期实体瘤治疗重大突破！, objectType=article, longId=869846, objectId=74bb869846a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230616/1686931044843_5579292.jpg, objectUrl=/article/show_article.do?id=74bb869846a6, replyNumber=0, likeNumber=35, createdTime=2025-03-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74bb869846a6, moduleTitle=中国原研ADC药物YL201实现晚期实体瘤治疗重大突破！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74bb869846a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2254790, encodeId=0c472254e903d, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=2fbd12485119' target=_blank style='color:#2F92EE;'>#CAR-NK细胞疗法#</a>, objectTitle=STTT：突破实体瘤治疗困境，曹雪涛院士团队发表论文揭示CAR-NK细胞疗法新机制, objectType=article, longId=865687, objectId=30ab86568e8a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719485454830_5579292.jpg, objectUrl=/article/show_article.do?id=30ab86568e8a, replyNumber=0, likeNumber=39, createdTime=2025-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=30ab86568e8a, moduleTitle=STTT：突破实体瘤治疗困境，曹雪涛院士团队发表论文揭示CAR-NK细胞疗法新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30ab86568e8a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2252474, encodeId=c63922524e4ac, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, objectTitle=肿瘤治疗的“王炸组合”来袭！结直肠癌、肺癌、血液肿瘤全面突破！这些进展值得重点关注, objectType=article, longId=863621, objectId=7cdb8636214f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230607/1686120557420_5579292.jpg, objectUrl=/article/show_article.do?id=7cdb8636214f, replyNumber=0, likeNumber=39, createdTime=2025-02-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=7cdb8636214f, moduleTitle=肿瘤治疗的“王炸组合”来袭！结直肠癌、肺癌、血液肿瘤全面突破！这些进展值得重点关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cdb8636214f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2248260, encodeId=6a5f2248260cc, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=9cc312336378' target=_blank style='color:#2F92EE;'>#罕见遗传结构变异#</a>, objectTitle=Science：儿童实体瘤的罕见遗传结构变异图谱发布！, objectType=article, longId=859708, objectId=ae50859e08aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019090215_4754896.png, objectUrl=/article/show_article.do?id=ae50859e08aa, replyNumber=0, likeNumber=39, createdTime=2025-01-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ae50859e08aa, moduleTitle=Science：儿童实体瘤的罕见遗传结构变异图谱发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae50859e08aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247844, encodeId=482c224e844a9, content=<a href='/topic/show?id=3c1ee4340c9' target=_blank style='color:#2F92EE;'>#神经母细胞瘤#</a> <a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=a8d71232649c' target=_blank style='color:#2F92EE;'>#生殖系结构变异#</a>, objectTitle=Science：罕见的生殖系结构变异增加儿童实体瘤的风险, objectType=article, longId=859095, objectId=4f2785909503, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250111/1736554167875_2185383.png, objectUrl=/article/show_article.do?id=4f2785909503, replyNumber=0, likeNumber=29, createdTime=2025-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247308, encodeId=1d1a224e30846, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=6ecd1231e5d7' target=_blank style='color:#2F92EE;'>#纳米铝佐剂#</a>, objectTitle=张凌宵/董明东/许志平Biomaterials：纳米铝佐剂抗原便利贴用于实体瘤“贴哪打哪”精准治疗, objectType=article, longId=858870, objectId=a9af8588e089, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720665813971_5579292.jpg, objectUrl=/article/show_article.do?id=a9af8588e089, replyNumber=0, likeNumber=42, createdTime=2025-01-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a9af8588e089, moduleTitle=张凌宵/董明东/许志平Biomaterials：纳米铝佐剂抗原便利贴用于实体瘤“贴哪打哪”精准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9af8588e089)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243195, encodeId=7dc32243195d7, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>, objectTitle=FDA发布《ctDNA用于治疗性实体瘤药物开发的行业指南》，为以ctDNA为生物标志物的临床试验提供指导, objectType=article, longId=855599, objectId=c34685559909, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241217/1734427792322_8538692.jpg, objectUrl=/article/show_article.do?id=c34685559909, replyNumber=0, likeNumber=54, createdTime=2024-12-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c34685559909, moduleTitle=FDA发布《ctDNA用于治疗性实体瘤药物开发的行业指南》，为以ctDNA为生物标志物的临床试验提供指导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c34685559909)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242694, encodeId=cc5922426949d, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=CAR-T治疗实体瘤获得实质性突破！IL-15加持、靶向GPC3；发表于Nature, objectType=article, longId=855384, objectId=41f485538431, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721893810359_8538692.png, objectUrl=/article/show_article.do?id=41f485538431, replyNumber=0, likeNumber=51, createdTime=2024-12-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=41f485538431, moduleTitle=CAR-T治疗实体瘤获得实质性突破！IL-15加持、靶向GPC3；发表于Nature, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41f485538431)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

实体瘤

2020-05-29

showtest (审核中...)

前往app查看评论内容

全文收起 #德喜曲妥珠单抗#（#Enhertu#，#DS-8201#）II期临床数据在泛HER2表达晚期#实体瘤#的持久反应，Enhertu（5.4mg/kg）治疗HER2表达肿瘤的疗效和安全性，包括#胆道癌#、#膀胱癌#、#宫颈癌#、#子宫内膜癌#、#卵巢癌#、#胰腺癌#和罕见肿瘤。#阿斯利康#和#第一三共#会收获很多，#FDA#大概率会批准Enhertu为HER2阳性#泛癌肿适应症#！这就牛了，是#HER2阳性#第一个靶向药物。

德喜曲妥珠单抗（Enhertu）II期临床数据在泛HER2表达晚期实体瘤的持久反应（DESTINY-PanTumor02研究）

2023-03-11发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #抗体偶联药物#

读书报告 | 靶向B7H3的ADC在进展期实体瘤的I/Ib期研究

2025-07-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #放射性药物#

Science Adv：放射性药物疗法联合CAR-T助力实体瘤治疗

2025-07-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #醛缩酶# #F-肌动蛋白波#

2025-07-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #特瑞普利单抗#

STTT：四川大学郑莉等团队研究调查了onatasertib联合特瑞普利单抗治疗晚期实体瘤患者的安全性、耐受性和有效性

2025-07-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #CAR-T细胞# #Eva1#

2025-06-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #CAR-T#

Cell：新型CAR-T细胞分子设计方式可加强对实体瘤的杀伤特异性

2025-05-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #肿瘤预后评分#

Royal Marsden医院的肿瘤预后评分（RMH得分）

2025-05-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #KRASG12C突变# #D3S-001#

Nat. Med | 新一代KRAS抑制剂D3S-001在KRASG12C突变实体瘤中的I期临床试验：安全性和抗肿瘤活性的初步评估

2025-05-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #T细胞治疗#

读书报告 | T细胞治疗引领实体瘤治疗潮流

2025-05-09发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #小细胞外囊泡#

减少自相残杀！CAR-T细胞疗法新进展，最新Nature Cancer！

2025-04-21

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #脑膜转移#

大咖谈 | 实体瘤柔脑膜转移的诊断和治疗

2025-04-07

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #抗体偶联药物#

中国原研ADC药物YL201实现晚期实体瘤治疗重大突破！

2025-03-31

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #CAR-NK细胞疗法#

STTT：突破实体瘤治疗困境，曹雪涛院士团队发表论文揭示CAR-NK细胞疗法新机制

2025-03-05发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #肿瘤治疗#

肿瘤治疗的“王炸组合”来袭！结直肠癌、肺癌、血液肿瘤全面突破！这些进展值得重点关注

2025-02-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #罕见遗传结构变异#

Science：儿童实体瘤的罕见遗传结构变异图谱发布！

2025-01-16发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#神经母细胞瘤# #实体瘤# #生殖系结构变异#

2025-01-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #纳米铝佐剂#

张凌宵/董明东/许志平Biomaterials：纳米铝佐剂抗原便利贴用于实体瘤“贴哪打哪”精准治疗

2025-01-09发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #实体瘤#

FDA发布《ctDNA用于治疗性实体瘤药物开发的行业指南》，为以ctDNA为生物标志物的临床试验提供指导

2024-12-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #CAR-T#

CAR-T治疗实体瘤获得实质性突破！IL-15加持、靶向GPC3；发表于Nature

2024-12-15发表于陕西省

科室
- - 订阅+
  - 更多科室
工具
服务